APA (7th ed.) Citation

E, W., T, S., G, S., J, B., C, L., JY, P., . . . SL, S. (2026). Voriconazole therapy and CYP2C19 phenotype: Identifying patients who may need alternative antifungal therapy. The Journal of antimicrobial chemotherapy, 81(6), . https://doi.org/10.1093/jac/dkag168

Chicago Style (17th ed.) Citation

E, Wehbe, et al. "Voriconazole Therapy and CYP2C19 Phenotype: Identifying Patients Who May Need Alternative Antifungal Therapy." The Journal of Antimicrobial Chemotherapy 81, no. 6 (2026). https://doi.org/10.1093/jac/dkag168.

MLA (9th ed.) Citation

E, Wehbe, et al. "Voriconazole Therapy and CYP2C19 Phenotype: Identifying Patients Who May Need Alternative Antifungal Therapy." The Journal of Antimicrobial Chemotherapy, vol. 81, no. 6, 2026, https://doi.org/10.1093/jac/dkag168.